Regulatory Submission in Europe in Absence of Reference product [Regulatives / Guidelines]

posted by drgunasakaran1  – 2021-05-20 09:20 (1507 d 05:06 ago) – Posting: # 22360
Views: 4,888

Dear Abhay Patil,

❝ The Individual product are present in Europe for more than 20 years and their equivalent Generics too available and filed under WEU. so in such case is it necessary to do BABE study


Yes. We need to conduct studies even though equivalent Individual Product Generics are available in the EU Market.

Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,684 registered users;
43 visitors (0 registered, 43 guests [including 13 identified bots]).
Forum time: 14:27 CEST (Europe/Vienna)

In the field of observation,
chance favors only the mind that is prepared.    Louis Pasteur

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5